Related references
Note: Only part of the references are listed.Development of transient radioresistance during fractionated irradiation in vitro
Jaap van den Berg et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens
Sarah Meneceur et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Glioblastoma's Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
Seamus Caragher et al.
CANCERS (2019)
Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells
Ross D. Carruthers et al.
CANCER RESEARCH (2018)
K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
Lukas Klumpp et al.
CURRENT NEUROPHARMACOLOGY (2018)
Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
Ha S. Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
Sandra Bien-Moeller et al.
STEM CELLS INTERNATIONAL (2018)
Tumor heterogeneity determined with a gamma H2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models
Treewut Rassamegevanon et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Ex vivo gamma H2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity
Chiara De-Colle et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines
Franziska Hauth et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2017)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
Apostolos Menegakis et al.
RADIOTHERAPY AND ONCOLOGY (2015)
γH2AX assay in ex vivo irradiated tumour specimens: A novel Method to determine tumour radiation sensitivity in patient-derived material
Apostolos Menegakis et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
Ross Carruthers et al.
MOLECULAR ONCOLOGY (2015)
Cancer stem cells and radioresistance
Kiera Rycaj et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Brain tumor stem cells: Molecular characteristics and their impact on therapy
David L. Schonberg et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
Longitudinal Expression Analysis of αv Integrins in Human Gliomas Reveals Upregulation of Integrin αvβ3 as a Negative Prognostic Factor
Jens Schittenhelm et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Residual γH2AX foci predict local tumour control after radiotherapy
Ulrike Koch et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Use of the γ-H2AX assay to monitor DNA damage and repair in cancer research
Alesia Ivashkevich et al.
CANCER LETTERS (2012)
A Role for Homologous Recombination and Abnormal Cell-Cycle Progression in Radioresistance of Glioma-Initiating Cells
Yi Chieh Lim et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours
Apostolos Menegakis et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Retention of γH2AX foci as an indication of lethal DNA damage
Peggy L. Olive
RADIOTHERAPY AND ONCOLOGY (2011)
Isolation and Expansion of Human Glioblastoma Multiforme Tumor Cells Using the Neurosphere Assay
Hassan Azari et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
Massimo Squatrito et al.
CANCER CELL (2010)
Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gamma H2AX staining
Apostolos Menegakis et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
Mingyu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
H. S. Guenther et al.
ONCOGENE (2008)
Exploring the role of cancer stem cells in radioresistance
Michael Baumann et al.
NATURE REVIEWS CANCER (2008)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Successful therapy must eradicate cancer stem cells
David Dingli et al.
STEM CELLS (2006)
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line
T Kondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)